C259H156Li6N18O6S2+6 — CID 158850440
hexalithium;5-[6-[4-(1,3-benzothiazol-2-yl)phenyl]pyren-1-yl]quinolin-1-ium-8-olate;7-[6-(1,3-benzothiazol-2-yl)pyren-1-yl]quinolin-1-ium-8-olate;5-[2'-(4,6-diphenyl-1,3,5-triazin-2-yl)-9,9'-spirobi[fluorene]-2-yl]quinolin-1-ium-8-olate;7-[2'-(4,6-diphenyl-1,3,5-triazin-2-yl)-9,9'-spirobi[fluorene]-2-yl]quinolin-1-ium-8-olate;5-[2-[4-(1-phenylbenzimidazol-2-yl)phenyl]-9,9'-spirobi[fluorene]-2'-yl]quinolin-1-ium-8-olate;5-(2'-pyrimidin-5-yl-9,9'-spirobi[fluorene]-2-yl)quinolin-1-ium-8-olate (PubChem CID 158850440) has the molecular formula C259H156Li6N18O6S2+6 and a molecular weight of 3722.00 g/mol. Its IUPAC name is hexalithium;5-[6-[4-(1,3-benzothiazol-2-yl)phenyl]pyren-1-yl]quinolin-1-ium-8-olate;7-[6-(1,3-benzothiazol-2-yl)pyren-1-yl]quinolin-1-ium-8-olate;5-[2'-(4,6-diphenyl-1,3,5-triazin-2-yl)-9,9'-spirobi[fluorene]-2-yl]quinolin-1-ium-8-olate;7-[2'-(4,6-diphenyl-1,3,5-triazin-2-yl)-9,9'-spirobi[fluorene]-2-yl]quinolin-1-ium-8-olate;5-[2-[4-(1-phenylbenzimidazol-2-yl)phenyl]-9,9'-spirobi[fluorene]-2'-yl]quinolin-1-ium-8-olate;5-(2'-pyrimidin-5-yl-9,9'-spirobi[fluorene]-2-yl)quinolin-1-ium-8-olate.
| Compound Name | hexalithium;5-[6-[4-(1,3-benzothiazol-2-yl)phenyl]pyren-1-yl]quinolin-1-ium-8-olate;7-[6-(1,3-benzothiazol-2-yl)pyren-1-yl]quinolin-1-ium-8-olate;5-[2'-(4,6-diphenyl-1,3,5-triazin-2-yl)-9,9'-spirobi[fluorene]-2-yl]quinolin-1-ium-8-olate;7-[2'-(4,6-diphenyl-1,3,5-triazin-2-yl)-9,9'-spirobi[fluorene]-2-yl]quinolin-1-ium-8-olate;5-[2-[4-(1-phenylbenzimidazol-2-yl)phenyl]-9,9'-spirobi[fluorene]-2'-yl]quinolin-1-ium-8-olate;5-(2'-pyrimidin-5-yl-9,9'-spirobi[fluorene]-2-yl)quinolin-1-ium-8-olate |
|---|---|
| PubChem CID | 158850440 |
| Molecular Formula | C259H156Li6N18O6S2+6 |
| Molecular Weight | 3722.00 g/mol |
| Exact Mass | 3719.28 |
| IUPAC Name | hexalithium;5-[6-[4-(1,3-benzothiazol-2-yl)phenyl]pyren-1-yl]quinolin-1-ium-8-olate;7-[6-(1,3-benzothiazol-2-yl)pyren-1-yl]quinolin-1-ium-8-olate;5-[2'-(4,6-diphenyl-1,3,5-triazin-2-yl)-9,9'-spirobi[fluorene]-2-yl]quinolin-1-ium-8-olate;7-[2'-(4,6-diphenyl-1,3,5-triazin-2-yl)-9,9'-spirobi[fluorene]-2-yl]quinolin-1-ium-8-olate;5-[2-[4-(1-phenylbenzimidazol-2-yl)phenyl]-9,9'-spirobi[fluorene]-2'-yl]quinolin-1-ium-8-olate;5-(2'-pyrimidin-5-yl-9,9'-spirobi[fluorene]-2-yl)quinolin-1-ium-8-olate |
| SMILES | [Li+].[Li+].[Li+].[Li+].[Li+].[Li+].[O-]c1c(-c2ccc3c(c2)C2(c4ccccc4-c4ccc(-c5nc(-c6ccccc6)nc(-c6ccccc6)n5)cc42)c2ccccc2-3)ccc2ccc[nH+]c12.[O-]c1c(-c2ccc3ccc4c(-c5nc6ccccc6s5)ccc5ccc2c3c54)ccc2ccc[nH+]c12.[O-]c1ccc(-c2ccc3c(c2)C2(c4ccccc4-c4ccc(-c5ccc(-c6nc7ccccc7n6-c6ccccc6)cc5)cc42)c2ccccc2-3)c2ccc[nH+]c12.[O-]c1ccc(-c2ccc3c(c2)C2(c4ccccc4-c4ccc(-c5cncnc5)cc42)c2ccccc2-3)c2ccc[nH+]c12.[O-]c1ccc(-c2ccc3c(c2)C2(c4ccccc4-c4ccc(-c5nc(-c6ccccc6)nc(-c6ccccc6)n5)cc42)c2ccccc2-3)c2ccc[nH+]c12.[O-]c1ccc(-c2ccc3ccc4c(-c5ccc(-c6nc7ccccc7s6)cc5)ccc5ccc2c3c54)c2ccc[nH+]c12 |
| InChI | InChI=1S/C53H33N3O.2C49H30N4O.C38H23N3O.C38H22N2OS.C32H18N2OS.6Li/c57-50-29-28-38(43-15-10-30-54-51(43)50)36-25-27-42-40-14-5-7-17-45(40)53(47(42)32-36)44-16-6-4-13-39(44)41-26-24-35(31-46(41)53)33-20-22-34(23-21-33)52-55-48-18-8-9-19-49(48)56(52)37-11-2-1-3-12-37;54-45-35(24-21-30-16-11-27-50-44(30)45)33-22-25-38-36-17-7-9-19-40(36)49(42(38)28-33)41-20-10-8-18-37(41)39-26-23-34(29-43(39)49)48-52-46(31-12-3-1-4-13-31)51-47(53-48)32-14-5-2-6-15-32;54-44-26-25-34(39-18-11-27-50-45(39)44)32-21-23-37-35-16-7-9-19-40(35)49(42(37)28-32)41-20-10-8-17-36(41)38-24-22-33(29-43(38)49)48-52-46(30-12-3-1-4-13-30)51-47(53-48)31-14-5-2-6-15-31;42-36-16-15-26(31-8-5-17-41-37(31)36)24-12-14-30-28-7-2-4-10-33(28)38(35(30)19-24)32-9-3-1-6-27(32)29-13-11-23(18-34(29)38)25-20-39-22-40-21-25;41-33-20-19-28(31-4-3-21-39-37(31)33)27-16-12-24-13-17-29-26(15-11-23-14-18-30(27)36(24)35(23)29)22-7-9-25(10-8-22)38-40-32-5-1-2-6-34(32)42-38;35-31-24(15-11-20-4-3-17-33-30(20)31)21-12-7-18-9-14-23-25(32-34-26-5-1-2-6-27(26)36-32)16-10-19-8-13-22(21)28(18)29(19)23;;;;;;/h1-32,57H;2*1-29,54H;1-22,42H;1-21,41H;1-17,35H;;;;;;/q;;;;;;6*+1 |
| InChIKey | IZJOAEAOYRWYFF-UHFFFAOYSA-N |
| XLogP | 37.28 |
| TPSA | 369.92 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 20 |
| Rotatable Bonds | 19 |
| Heavy Atoms | 291 |
| Complexity | — |
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 3722.00 |
| LogP ≤ 5 | 37.28 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 20 |